Trending...
- Red Light Therapy: A Breakthrough Treatment for Aging Eyesight
- The Millennium Alliance Is Recognized As A Top Workplace In New York City
- Celebrate Black Music Month — An Unforgettable Evening with Morace Landy: Music Industry Legend & CEO, Evolution3, June 6, 6-8:30 PM, Harlem, NY
Eve Wellness located in SF offers the first FDA-approved ultrasound screening technology specifically designed for detecting cancer in dense breast tissue.
SAN FRANCISCO - Nyenta -- Eve Wellness, a San Francisco-based breast cancer screening clinic, is leading the charge in breast cancer screening by providing women the opportunity to get screened earlier, at any age, without a doctor referral, using their FDA-Approved GE ABUS ultrasound technology, powered by FDA-Approved AI (artificial intelligence), all without radiation. This comes on the heels of the FDA's new mandate, announced on March 9, 2023, requiring all mammography facilities to report breast density information and enhance communications with patients and providers.
The FDA's move is important because the risk of breast cancer is of real concern to many patients, said Dr. Harold Burstein, a medical oncologist at the Dana-Farber Cancer Institute in Boston and a professor at Harvard Medical School. "The identification of dense breast tissue can be a marker of slightly greater risk of getting breast cancer, and it may need additional breast imaging," said Burstein, who likened the challenge of reading mammograms to "looking through frosted glass."
More on Nyenta.com
Breast density has been identified as a risk factor for breast cancer, and the FDA's new mandate aims to increase awareness and understanding of this risk. The mandate requires mammography facilities to provide patients with information about their breast density and the impact it can have on the accuracy of mammograms. Facilities are also required to communicate the findings with healthcare providers and provide recommendations for additional screening options, such as breast ultrasound.
"Today's action represents the agency's broader commitment to support innovation to prevent, detect and treat cancer," said Hilary Marston, M.D., M.P.H., FDA's Chief Medical Officer. "Since 1992, the FDA has worked to ensure patients have access to quality mammography. The impact of the Mammography Quality Standards Act on public health has been significant, including a steep decrease in the number of facilities that do not meet quality standards. This means that more women have access to consistent, quality mammography. We remain committed to advancing efforts to improve the health of women and strengthen the fight against breast cancer."
At Eve Wellness, breast ultrasound is the best option for women with dense breast tissue. Their GE ABUS ultrasound technology, powered by AI, can detect breast cancer at an earlier stage and without the use of radiation. With physician-read results back in less than 48 hours, Eve Wellness provides women with quick results, reducing anxiety and enabling early intervention.
More on Nyenta.com
"Breast cancer claims the lives of nearly 43,000 women annually, and early detection is key to improving outcomes. Eve is on a mission to fill the void in breast cancer screening," said Brendan Foley, Co-Founder at Eve Wellness. "We are proud to lead the change in breast screening by providing women with access to the latest technology and empowering them to take control of their breast health."
Eve Wellness is committed to providing women with the best possible breast cancer screening options and is a game-changer in the fight against breast cancer. With the FDA's new mandate, women can feel more informed and empowered in their breast health decisions, and Eve Wellness is here to support them every step of the way.
For more information on Eve Wellness and their breast cancer screening services, visit their website at https://www.myevewellness.com/.
The FDA's move is important because the risk of breast cancer is of real concern to many patients, said Dr. Harold Burstein, a medical oncologist at the Dana-Farber Cancer Institute in Boston and a professor at Harvard Medical School. "The identification of dense breast tissue can be a marker of slightly greater risk of getting breast cancer, and it may need additional breast imaging," said Burstein, who likened the challenge of reading mammograms to "looking through frosted glass."
More on Nyenta.com
- Kessler Topaz Meltzer & Check, LLP Reminds Icahn Enterprises L.P. (IEP) Investors of July 10, 2023 Lead Plaintiff Deadline and Urges Investors with Substantial Losses to Contact the Firm
- How to Navigate Hormonal Mayhem: A Groundbreaking Book on Perimenopause, Endometriosis, and Beyond
- Rochester: Mayor Evans Encourages Residents to Heed Monroe County Department of Health Advisories
- Get Ready for Fireworks in Sexy Red, White, and Blue Bustier Babydoll Lingerie
- THE SALMON FACTOR WINS GOLD EFFIE AWARD IN THE UNITED STATES USA - English España - español
Breast density has been identified as a risk factor for breast cancer, and the FDA's new mandate aims to increase awareness and understanding of this risk. The mandate requires mammography facilities to provide patients with information about their breast density and the impact it can have on the accuracy of mammograms. Facilities are also required to communicate the findings with healthcare providers and provide recommendations for additional screening options, such as breast ultrasound.
"Today's action represents the agency's broader commitment to support innovation to prevent, detect and treat cancer," said Hilary Marston, M.D., M.P.H., FDA's Chief Medical Officer. "Since 1992, the FDA has worked to ensure patients have access to quality mammography. The impact of the Mammography Quality Standards Act on public health has been significant, including a steep decrease in the number of facilities that do not meet quality standards. This means that more women have access to consistent, quality mammography. We remain committed to advancing efforts to improve the health of women and strengthen the fight against breast cancer."
At Eve Wellness, breast ultrasound is the best option for women with dense breast tissue. Their GE ABUS ultrasound technology, powered by AI, can detect breast cancer at an earlier stage and without the use of radiation. With physician-read results back in less than 48 hours, Eve Wellness provides women with quick results, reducing anxiety and enabling early intervention.
More on Nyenta.com
- Financial IT Launches Fintech Pathfinder: Showcasing the Most Promising Fintech Startups
- Return of Professional Basketball to Quebec City
- Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support WisdomTree's New Director Nominee Shamla Naidoo and Recommend Against ETFS Capital Chairman Graham Tuckwell
- Wágner Resurfaces with Second Single "I Ran" After 30-Year Hiatus
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tingo Group, Inc. - TIO
"Breast cancer claims the lives of nearly 43,000 women annually, and early detection is key to improving outcomes. Eve is on a mission to fill the void in breast cancer screening," said Brendan Foley, Co-Founder at Eve Wellness. "We are proud to lead the change in breast screening by providing women with access to the latest technology and empowering them to take control of their breast health."
Eve Wellness is committed to providing women with the best possible breast cancer screening options and is a game-changer in the fight against breast cancer. With the FDA's new mandate, women can feel more informed and empowered in their breast health decisions, and Eve Wellness is here to support them every step of the way.
For more information on Eve Wellness and their breast cancer screening services, visit their website at https://www.myevewellness.com/.
Source: Eve Wellness, Inc.
0 Comments
Latest on Nyenta.com
- KYC2020 Offers Free Sanctions Screening for Non-Commercial Use
- Introducing RecipeNFT: The Revolutionary Platform for Preserving Family Recipes on the Avalanche Blockchain
- Introducing Obitz.io: Revolutionizing Obituaries with Blockchain Technology
- Bronx Chiropractor, Dr. Ralph Napolitano, Expands Practice to Serve Bronx and Brooklyn
- New Epic Fantasy - Shadow of the Soul Blade By Jay Roland
- Wallaroo.AI Launches Unique Workload Orchestration Capabilities to Help Scale Production Machine Learning (ML) Workflows 5- 10x, with 40% Time Savings
- BURFORD CAPITAL TO HOST GLOBAL RETAIL SHAREHOLDER CALL ON JUNE 21, 2023
- Bent Danholm of MAXIM Realty Orlando Joins Forces With Tech Company to Improve Target Marketing of Homes in Central Florida
- VenturSeed Machine-Learning/Artificial Intelligence Labs Launches for Students and Promising Pre-Pre Seed Startups
- ERC Deadline (June 2023): Employee Retention Credit Deadline Guidance Shared by Better Business Advice
- Rochester: J.U.S.T. L.A.W. Initiative Student Essay Winners to be Recognized at Awards Ceremony
- Bit Digital, Inc. Announces Monthly Production Update for May 2023
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NextEra Energy, Inc. - NEE
- Stapleton Group and Sorokin & Associates Announce Strategic Partnership
- Politan Comments on Masimo's Recent Board Announcement
- Blue Collar Barons Launches as the First Construction-themed NFT Web3 Game
- Ashtyn Montgomery and Cruz Textures Partner with Doe Sports
- JustFoodForDogs In-Store Kitchen Now Open at Petco's Union Square Location
- Loretta Ana Kaufman to Exhibit in The National Association of Women Artists 134th Annual Exhibition
- KBRA Assigns Preliminary Ratings to GLS Auto Select Receivables Trust 2023-1